Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to 10.39%.

  • Medifast's EBIT Margin fell 109900.0% to 10.39% in Q4 2025 from the same period last year, while for Dec 2025 it was 3.68%, marking a year-over-year decrease of 41600.0%. This contributed to the annual value of 3.68% for FY2025, which is 41600.0% down from last year.
  • As of Q4 2025, Medifast's EBIT Margin stood at 10.39%, which was down 109900.0% from 4.56% recorded in Q3 2025.
  • In the past 5 years, Medifast's EBIT Margin registered a high of 15.58% during Q2 2021, and its lowest value of 10.39% during Q4 2025.
  • Moreover, its 5-year median value for EBIT Margin was 10.23% (2022), whereas its average is 6.57%.
  • As far as peak fluctuations go, Medifast's EBIT Margin plummeted by -177400bps in 2024, and later surged by 36600bps in 2025.
  • Medifast's EBIT Margin (Quarter) stood at 12.4% in 2021, then decreased by -22bps to 9.67% in 2022, then tumbled by -53bps to 4.54% in 2023, then crashed by -87bps to 0.6% in 2024, then crashed by -1844bps to 10.39% in 2025.
  • Its last three reported values are 10.39% in Q4 2025, 4.56% for Q3 2025, and 1.01% during Q2 2025.